Galapagos gains $3.7M for CF drug

The Flemish agency for Innovation by Science and Technology has handed Galapagos $5.1 million (€3.7 million) grant for preclinical drug work on cystic fibrosis. Galapagos will collaborate on this project with the Center for Human Genetics at the KU Leuven. The company says the funding increases the chances that it will have a preclinical drug candidate in 2013. Release